SOD1 and prostate cancer: The current finding that the activities of the antioxidant enzymes (SOD and GPx) decreased significantly (P < 0.05) in PCa patients when compared with control subjects is also consistent with earlier studies by Aydin et al. [27] who reported that the levels of glutathione peroxidase and superoxide dismutase were decreased in prostate cancer.